Security key
G9TY5A101
Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (ZURA)
CUSIP: G9TY5A101
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Class A Ordinary Shares, par value $0.0001 per share
- Total 13F shares
- 32,818,331
- Total 13F value
- $114,851,034
- Share change
- +18,003,867
- SEC-reported price per share
- $3.50
- Number of holders
- 55
- Value change
- +$63,732,200
- Number of buys
- 37
- Number of sells
- 15
- Shares outstanding
- 99,155,394
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
55
Top holders
10
ZURA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Zura Bio Ltd SEC filings
Zura Bio Ltd company facts
Broader feeds
Reporting periods
Holder history for CUSIP G9TY5A101
Recent filing periods:
Ownership snapshot
Top reported holders of ZURA - Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BARCLAYS PLC
Disclosed value leader
BARCLAYS PLC
Comparable rows
0/15
Latest evidence
18 Jun 2024
3/4/5
13F
Highest disclosed value: $24,349,729
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BARCLAYS PLC has the largest disclosed position value at $24.35M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BARCLAYS PLC's linked filing trail.
Disclosed position value
Top 5
BARCLAYS PLC
$24.35M
MONTANOVA CAPITAL, LLC
$7.32M
GREAT POINT PARTNERS LLC
$7.09M
Deep Track Capital, LP
$6.48M
ARMISTICE CAPITAL, LLC
$4.24M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BARCLAYS PLC |
3/4/5
13F
10%+ Owner · Company
|
—
denominator unverified
|
$24,349,729
2,340,240 shares
|
— | 09 Jan 2023 |
| Hana Immunotherapeutics LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
—
5,404,274 shares
|
— | 20 Mar 2023 |
| PFIZER INC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
—
2,970,022 shares
|
— | 20 Mar 2023 |
| Ewon Comfortech Co., Ltd. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
—
2,000,000 shares
|
— | 20 Mar 2023 |
| JATT Ventures, L.P. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
—
967,370 shares
|
— | 10 Feb 2023 |
| MONTANOVA CAPITAL, LLC |
13F
Company
|
—
denominator unverified
|
$7,324,500
2,850,000 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
55
Shares
32,818,331
Rows available
55
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
43
Q2 2024 holders
55
Holder diff
12
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend